Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.
S. Wring, R. Randolph, S. Park, G. Abruzzo, Q. Chen, A. Flattery, G. Garrett, M. Peel, R. Outcalt, K. Powell, M. Trucksis, D. Angulo, K. Borroto-Esoda
Antimicrobial Agents and Chemotherapy
March 2017